Clinical Trials Sponsored by CM&D Pharma, LTD

Total 16 results

CM&D Pharma Limited

Completed

Estrogen Receptor Beta Agonists (Eviendep) and Polyp Recurrence (CRC)

Adenocarcinoma of Colon Recurrent

Italy
Denver Nephrologists, P.C.
CM&D Pharma, LTD

Completed

Phosphate Binding of Chitosan Chewing Gum in Patients With Chronic Kidney Disease (CKD)

Chronic Kidney Disease

United States
MARIA CRISTINA COMELLI

Unknown

Safety and Efficacy Study of PEA and Polydatin on Intestinal Inflammation and Visceral Hyperalgesia in IBS Patients (CMD-IBS09(2))

Irritable Bowel Syndrome

Italy
Denver Nephrologists, P.C.
CM&D Pharma Limited

Completed

Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia

Chronic Kidney Disease | Hyperphosphatemia

United States
Denver Nephrologists, P.C.
CM&D Pharma Limited

Completed

Salivary Phosphorus and Level of Kidney Function

Chronic Kidney Disease

United States
Denver Nephrologists, P.C.
CM&D Pharma Limited

Completed

A Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease

Chronic Kidney Disease

United States
Denver Nephrologists, P.C.
CM&D Pharma Limited

Completed

PD Study to Assess Phosphate Binding Characteristics of K2CG Chewing Gum

Chronic Kidney Disease | Hyperphosphatemia

United States
D-Pharm Ltd.

Unknown

A Study of the Safety, Imaging and Clinical Outcomes of THR-18 in Acute Stroke Subjects Treated With tPA

Ischemic Stroke

Moldova, Republic of
D-Pharm Ltd.

Terminated

Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke (MACSI)

Acute Ischemic Stroke

Spain, Korea, Republic of, Israel, United States, France, Canada, Brazil, South Africa, Netherlands, Czech Republic, Austria, Germany, Italy, Hungary, Poland, Portugal, Slovakia, Switzerland
D-Pharm Ltd.

Withdrawn

DP-VPA for Migraine Prophylaxis, a Pilot Efficacy Study

Migraine

Israel
D-Pharm Ltd.

Terminated

DP-b99 in the Treatment of Acute High-risk Pancreatitis

Pancreatitis

Czech Republic
D-Pharm Ltd.

Completed

THR-18's Pharmacokinetics and Pharmacodynamics in Subjects With Acute Ischemic Stroke Treated With tPA

Stroke, Acute

Ukraine
D-Pharm Ltd.

Completed

Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke

Stroke | Cerebrovascular Disorders | Brain Ischemia

Israel, Germany
Luye Pharma Group Ltd.
SocraTec R&D GmbH; SocraMetrics GmbH

Completed

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (13.3mg/24h)

Healthy

Germany
SocraTec R&D GmbH
Luye Pharma Group Ltd.; SocraMetrics GmbH

Completed

Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease

Patch Adhesion | Local Tolerability

Germany
Kocak Farma
Novagenix Bioanalytical Drug R&D Center; Farmagen Ar-Ge Biyot. Ltd. Sti

Completed

Bioequivalence Study of Favir 200 mg Film Tablet Kocak Under Fasting Conditions

Bioequivalence

Turkey

Clinical Trials Sponsored by CM&D Pharma, LTD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations